These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6183698)

  • 21. [Interferons and their effects].
    Giese M; Kirchner H
    Onkologie; 1988 Aug; 11(4):151-4. PubMed ID: 2460811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferons and immune reactivity.
    Hooks JJ; Detrick-Hooks B; Levinson AI
    J Am Vet Med Assoc; 1982 Nov; 181(10):1111-4. PubMed ID: 6184354
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunology and interferons (author's transl)].
    Goudswaard J
    Tijdschr Diergeneeskd; 1982 Mar; 107(5):174-85. PubMed ID: 6175046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferons with special emphasis on the immune system.
    Friedman RM; Vogel SN
    Adv Immunol; 1983; 34():97-140. PubMed ID: 6195895
    [No Abstract]   [Full Text] [Related]  

  • 25. Noncytolytic control of viral infections by the innate and adaptive immune response.
    Guidotti LG; Chisari FV
    Annu Rev Immunol; 2001; 19():65-91. PubMed ID: 11244031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cellular base immunologic recognition. I. Relationship and cooperative interaction between subpopulations of T- and B-lymphocytes during the process of primary immunologic recognition].
    Brondz BD
    Usp Sovrem Biol; 1977; 84(5):219-35. PubMed ID: 27026
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interferon influences the immunologic defense of the body--an important physiological immunity-regulating function?].
    Kiessling R; Gidlund M
    Lakartidningen; 1985 Jul; 82(30-31):2593-7. PubMed ID: 2410747
    [No Abstract]   [Full Text] [Related]  

  • 28. NK cells and interferons.
    Paolini R; Bernardini G; Molfetta R; Santoni A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):113-20. PubMed ID: 25443799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
    Trinchieri G; Santoli D; Granato D; Perussia B
    Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
    Markovic SN; Murasko DM
    Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interferon system of teleost fish.
    Robertsen B
    Fish Shellfish Immunol; 2006 Feb; 20(2):172-91. PubMed ID: 15939626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of mitogenic factor, lymphocyte-activating factor and immune interferon in the induction of humoral and cell-mediated immunity.
    Farrar JJ; Simon PL; Farrar WL; Koopman WJ; Fuller-Bonar J
    Ann N Y Acad Sci; 1979; 332():303-15. PubMed ID: 161151
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary fat and immune function. I. Antibody responses, lymphocyte and accessory cell function in (NZB x NZW)F1 mice.
    Morrow WJ; Ohashi Y; Hall J; Pribnow J; Hirose S; Shirai T; Levy JA
    J Immunol; 1985 Dec; 135(6):3857-63. PubMed ID: 2415589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host factors important in immune surveillance against tumours.
    Ada GL
    IARC Sci Publ; 1982; (39):223-39. PubMed ID: 6185418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [differentiation and antigen recognition of sensitized lymphocytes--difference between effector cells for each type of immune reactions to xenogeneic erythrocytes (author's transl)].
    Kubo C
    Fukuoka Igaku Zasshi; 1980 May; 71(5):225-42. PubMed ID: 7399391
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated immunity: mechanisms, significance, and evaluation.
    Papageorgiou PS
    Pediatr Ann; 1976 Jun; 5(6):378-96. PubMed ID: 5697
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor activity of type I and type III interferons in BNL hepatoma model.
    Abushahba W; Balan M; Castaneda I; Yuan Y; Reuhl K; Raveche E; de la Torre A; Lasfar A; Kotenko SV
    Cancer Immunol Immunother; 2010 Jul; 59(7):1059-71. PubMed ID: 20217081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferons: cytokines in autoimmunity.
    Revel M; Schattner A
    Ciba Found Symp; 1987; 129():223-33. PubMed ID: 2445534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.